Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 2143-2148

  Janssen, Y J H ^a   Hamdy, N A T ^a   Frolich, M ^a   Roelfsema, F ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ESTROGEN; HUMAN GROWTH HORMONE; HYDROXYPROLINE; OSTEOCALCIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; BONE DENSITY; BONE GROWTH; BONE MASS; BONE METABOLISM; BONE TURNOVER; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSSIFICATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ALKALINE PHOSPHATASE; BONE DENSITY; BONE REMODELING; COLLAGEN; COLLAGEN TYPE I; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYDROXYPROLINE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDES; REFERENCE VALUES; TIME FACTORS;

EID: 0031764863     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.6.2143     Document Type: Article

References (30)

1. Jørgensen JO, Pedersen SA, Thuesen L, et al. 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1:1221-1225.
2. Cuneo RC, Salomon F, McGauley GA, Sönksen PH. 1992 The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 37:387-397.
3. Bengtsson BÅ, Eden S, Lonn L, et al. 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
4. De Boer H, Blok GJ, van der Veen EA. 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 16:63-86.
5. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab. 74:118-123.
6. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab. 76:1344-1348.
7. De Boer H, Blok GJ, van Lingen A, Teule GJ, Lips P, van der Veen EA. 1994 Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res. 9:1319-1326.
8. Degerblad M, Bengtsson BÅ, Bramnert M, et al. 1995 Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy. Eur J Endocrinol. 133:180-188.
9. Rosén T, Hansson T, Granhed H, Szucs J, Bengtsson BÅ. 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh). 129:201-206.
10. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab. 78:669-674.
11. Johannsson G, Rosén T, Bosaeus I, Sjöström L, Bengtsson BÅ. 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab. 81:2865-2873.
12. Baum HB, Biller BM, Finkelstein JS, et al. 1996 Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med. 125:883-890.
13. Finkenstedt G, Gasser RW, Hofle G, Watfah C, Fridrich L. 1997 Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up. Eur J Endocrinol. 136:282-289.
14. Holmes SJ, Mawer EB, Shalet SM. 1997 Effect of growth hormone replacement on calcium, phosphate, vitamin D and parathyroid hormone metabolism in adults with growth hormone deficiency. Endocrinology and Metabolism. 4:49-54.
15. Janssen YJ, Frölich M, Roelfsema F. 1997 A low starting dose of genotropin in growth hormone-deficient adults. J Clin Endocrinol Metab. 82:129-135.
16. WHO. 1994 Assessment of osteoporotic fracture risk and its role in screening for postmenopausal osteoporosis. Geneva: WHO Technical Report Series.
17. Prockop DJ, Udenfriend S. 1960 A specific method for the analysis of hydroxyproline in tissues and urine. Ann Biochem. 1:228-239.
18. Toogood AA, Adams JE, O'Neill PA, Shalet SM. 1997 Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab. 82:1462-1466.
19. Rosén T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson BÅ. 1993 Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol (Oxf). 38:63-71.
20. Hansen TB, Brixen K, Vahl N, et al. 1996 Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab. 81:3352-3359.
21. Blok GJ, van der Veen EA, Susgaard S, Larsen F. 1991 Influence of concentration and injection volume on the bioavailability of subcutaneous growth hormone: comparison of administration by ordinary syringe and by injection pen. Pharmacol Toxicol. 68:355-359.
22. Jørgensen JO, Moller J, Jensen FS, Jørgensen JT, Christiansen JS. 1989 Growth hormone administration by means of an injection pen. Pharmacol Toxicol. 65:96-49.
23. Verhelst J, Abs R, Vandeweghe M, et al. 1997 Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol (Oxf). 47:485-494.
24. Hahn TJ. 1978 Corticosteroid-induced osteopenia. Arch Intern Med. 138:882-885.
25. Klibanski A, Neer RM, Beitins IZ, Ridgway EC, Zervas NT, McArthur JW. 1980 Decreased bone density in hyperprolactinemic women. N Engl J Med. 303:1511-1514.
26. Klibanski A, Greenspan SL. 1986 Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med. 315:542-546.
27. Manning PJ, Evans MC, Reid IR. 1992 Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol (Oxf.) 36:229-234.
28. Richelson LS, Wahner HW, Melton LJ3, Riggs BL. 1984 Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med. 311:1273-1275.
29. Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F. 1989 A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone. 10:313-320.
30. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab. 79:470-479.